EAACI Portal

Eaaci: European Academy of Allergy and Clinical Immunology

It is our pleasure to announce that the late-breaking abstract submission is opening on 1 March 2015. Add your latest findings to the cutting edge science of EAACI Congress 2015 before 31 March 2015 and be part of the Scientific Programme. Visit the Congress website to register. The Preliminary Programme is also available here.

It is a great pleasure to invite you to the ISMA 2015 from 19 - 21 November 2015. We encourage you to save the date in your diary! The scientific highlights will address structural and functional biology of allergens, new developments in diagnostic methods and much more.Registration and Abstract submission will open soon. Information is regularly updated on www.eaaci-isma.org

PAAM 2015 will take place from 15 - 17 October and will bring together pediatricians and primary care physicians to discuss challenging scientific and clinical issues related to pediatric allergy and asthma.Registration and abstract submission are now open here. Please check the preliminary programme for further information.

SERIN 2015 welcomes specialists in the field of rhinology from all over the world and focuses on the latest knowledge in airway immunology. The abstract submission is now closed. We invite you to have a look at the diverse and stimulating scientific programme and register as soon as possible. More information is available here.

UPDATES

EU Affairs Monitoring Report

Have a look at the December 2014 and January 2015 EU Affairs Monitoring Report here.

Guideline on Allergen-specific Immunotherapy by the German, Austrian and Swiss National Societies

Guideline on allergen-specific immunotherapy (AIT) in IgE-mediated allergic diseases: please read more about the publication here.

Patients and doctors urge to put EU air quality policy back on the agenda

Brussels, 17 December 2014

The European Commission presented yesterday at the European Parliament plenary in Strasbourg, its 2015 working plan. Read more in the Press Release here.

Find EAACI in Social Media

Want to keep up to date with all EAACI news and deadlines? Why not follow us on Twitter and Instagram, like our page on Facebook or find us on LinkedIn and Google Plus? You can also post your photos from EAACI events as well as your views and opinions on a range of topics

Innovative treatments to control and identify severe asthma

Athens, Greece. 13 November 2014

Two new studies on the treatment and identification of severe asthma may have found new ways to control and identify this disease. Read more in the Press Release here, also available in SP, GR, DE, FR and IT.

Reducing the incidence of food allergy in children

Dublin, Ireland, 9 October 2014

The frequency of food allergic reactions is greater among children than among adults and up to 17% of the European population may be affected. During FAAM 2014 that took place in October, in Dublin two new studies focusing on the prevention of allergy in children were presented. Read more in the Press Release here, also available in Spanish.

Faster and accurate identification of drugs causing allergic reactions: a great relief for patients

Krakow (Poland), 18 September 2014

Cutaneous adverse drug reactions: Diagnosis of CADR could now improve significantly thanks to a new method developed by a group of researchers led by Dr Grzegorz Porebski, Jagiellonian University, Department of Clinical and Environmental Allergology (Krakow, Poland). Read more in the Press Release here.

Zurich, Switzerland 07.04.2014

– Anaphylaxis is increasingly found in allergic reactions in children, primarily caused by food allergies in this population group: up to 22% of European children have an allergy, with serious reaction to food on the rise1. The severity of its effects, which can be fatal, demands the attention not only of allergologists but of all healthcare professionals. This is one of the most important messages found in advance of the new guidelines on anaphylaxis on which the European Academy of Allergy and Clinical Immunology (EAACI) is currently working.

Berne (Switzerland), April 14th 2014 – Drug Hypersensitivity Reactions (DHRs) affect 7% of the general population and represent a major health problem, as they can be life-threatening and require or prolong hospitalisation. Furthermore, both underdiagnosis (as they are insufficiently detected) and overdiagnosis (due to excessive use of the term “allergy”) are common in clinical practice, and this can lead to the prescription of more expensive or less effective drugs.

EAACI was proud to join the European Chronic Disease Alliance (ECDA) at the first EU Summit on Chronic Diseases in Brussels from April 3-4. ECDA welcomed the Commission’s initiative to organise the Summit, which we hope to be a step towards an EU framework to allow the EU to make a significant impact in reaching the United Nations goal of a 25% reduction in premature mortality from chronic diseases by 2025.

Reflecting the feedback from our recent Membership Benefits Survey we are asking you to "Go green with EAACI" and offering the possibility to opt out from receiving printed versions of Allergy and/or Pediatric Allergy and Immunology by selecting the opt out box(es) at the Membership Profile Management Page.